calf
scour
primari
caus
morbid
mortal
dairi
industri
effect
treatment
need
minim
death
maxim
welfar
maintain
growth
product
object
trial
compar
efficaci
commerci
avail
nutrit
supplement
diaqu
boehringeringelheim
vetmedica
inc
st
joseph
mo
iv
lactat
ringer
solut
lr
rehydr
prevent
acidemia
correct
electrolyt
imbal
experiment
model
calf
scour
twentyfour
colostrumf
suckl
dairi
calv
use
modifi
crossov
design
osmot
diarrhea
induc
oral
feed
commerci
milk
replac
modifi
high
level
sucros
creat
hyperton
milk
solut
administ
oral
hydrochlorothiazid
spironolacton
h
intent
creat
challeng
suffici
result
moder
dehydr
stand
calv
without
produc
sever
depress
loss
suckl
efficaci
iv
fluid
therapi
commerci
nutrit
supplement
subsequ
compar
revers
effect
diarrheal
diseas
treatment
consist
administ
nutrit
supplement
accord
label
direct
g
l
warm
water
time
day
treatment
b
consist
iv
lr
l
day
clinic
sign
laboratori
result
obtain
daili
blind
observ
induct
method
effect
creat
desir
effect
demonstr
weight
loss
subject
health
hydrat
score
treatment
group
experienc
increas
bodi
weight
base
excess
bicarbon
decreas
total
protein
pack
cell
volum
follow
treatment
iv
lr
diaqu
effect
method
correct
hypovolemia
control
derang
acidbas
statu
calv
diarrhea
dehydr
calf
scour
account
major
prewean
dairi
calf
morbid
mortal
usda
second
respiratori
diseas
morbid
beef
calv
usda
econom
effect
diarrheal
diseas
calv
limit
mortal
includ
cost
treatment
well
notabl
neg
effect
calf
growth
futur
perform
donovan
et
al
diarrhea
young
calv
multifactori
affect
manag
hygien
immun
statu
nutrit
calf
well
burden
infecti
agent
foster
smith
common
pathogen
enterotoxigen
escherichia
coli
cryptosporidium
parvum
rotaviru
coronaviru
howev
mix
etiolog
common
field
condit
attempt
distinguish
agent
unreward
left
untreat
dehydr
subsequ
scour
lead
decreas
appetit
electrolyt
metabol
imbal
increas
suscept
secondari
diseas
although
antimicrobi
ancillari
therapi
may
warrant
calv
show
system
ill
constabl
smith
mainstay
treatment
entail
address
loss
fluid
electrolyt
success
treatment
depend
upon
earli
detect
intervent
protocol
rehydr
calv
also
maintain
hydrat
electrolyt
balanc
face
ongo
loss
ideal
treatment
dehydr
diarrheic
calv
achiev
minim
labor
time
intens
easi
administ
littl
risk
user
error
insult
calf
part
protocol
straightforward
easili
trainabl
employe
mcguirk
intraven
fluid
proven
effect
treatment
diarrheic
calv
constabl
howev
administr
time
consum
invas
requir
rel
high
level
employe
train
skill
oral
rehydr
therapi
ort
long
accept
altern
iv
fluid
therapi
extens
variabl
present
ort
product
market
thu
product
assum
equal
effect
rehydr
correct
electrolyt
acidbas
imbal
current
recommend
state
ort
product
meet
follow
criteria
smith
suppli
suffici
sodium
normal
extracellular
fluid
volum
provid
agent
glucos
citrat
acet
facilit
absorpt
sodium
water
intestin
provid
alkalin
agent
acet
propion
bicarbon
correct
maintain
acidbas
statu
provid
energi
calv
diarrhea
neg
energi
balanc
commerci
avail
product
diaqu
boehringeringelheim
vetmedica
inc
st
joseph
mo
oral
rehydr
nutrit
supplement
satisfi
criteria
also
contain
addit
nutrient
constitu
includ
protein
fat
addit
glucos
commerci
avail
product
compar
iv
fluid
therapi
treatment
diarrheic
moder
dehydr
calv
use
product
instead
iv
therapi
would
benefici
beef
dairi
calf
rais
industri
could
give
produc
viabl
less
laborintens
option
help
achiev
goal
success
calf
diarrhea
dehydr
manag
null
hypothesi
iv
fluid
would
effect
oral
supplement
rehydr
maintain
acidbas
electrolyt
balanc
diarrheic
calv
object
studi
compar
efficaci
nutrit
supplement
ort
iv
administ
lactat
ringer
solut
lr
rehydr
maintain
acidbas
balanc
limit
electrolyt
derang
moder
dehydr
diarrheic
calv
twentyfour
healthi
colostrumf
dairi
bull
freemartin
calv
use
transport
dalhart
texa
stillwat
oklahoma
hous
oklahoma
state
univers
laboratori
anim
research
center
calv
hous
group
indoor
forcedair
climat
control
environ
throughout
studi
calv
fed
milk
replac
bottl
twice
daili
volum
equal
approxim
mean
bw
per
day
anim
ad
libitum
access
starter
feed
throughout
project
access
water
acclim
washout
period
calv
given
least
acclim
transport
onset
initi
induct
procedur
studi
conduct
conform
univers
institut
anim
care
use
polici
anim
care
use
protocol
vm
number
observ
base
upon
intent
assess
noninferior
oral
supplement
compar
iv
fluid
follow
assumpt
power
differ
treatment
measur
bw
chang
initi
treatment
end
studi
equal
standard
deviat
effect
case
estim
kg
approxim
mean
bw
enrol
calv
allow
maintain
power
despit
loss
followup
due
death
withdraw
observ
period
studi
design
crossov
washout
period
studi
period
calv
initi
divid
group
one
group
underw
induct
treatment
first
trial
period
wherea
group
remain
unenrol
upon
complet
first
studi
period
second
group
underw
induct
treatment
second
studi
period
wherea
first
group
complet
washout
period
calv
first
group
reenrol
third
studi
period
wherea
second
group
washout
due
health
complic
relat
studi
protocol
other
calv
abl
particip
period
initi
intend
enrol
case
calf
elig
enrol
next
studi
period
follow
resolut
health
issu
result
modif
true
crossov
design
necessit
fifth
studi
period
calv
within
group
initi
block
bw
randomli
assign
treatment
first
trial
period
calf
enrol
opposit
treatment
subsequ
period
gener
calv
underw
studi
period
one
treatment
howev
calv
use
studi
period
case
assign
calf
treatment
group
third
treatment
done
randomli
treatment
protocol
consist
administ
nutrit
supplement
diaqu
see
tabl
nutrient
analysi
reconstitut
per
label
direct
g
l
warm
water
bottl
everi
h
time
day
consecut
day
treatment
protocol
b
consist
l
lr
administ
iv
bolu
infus
day
consecut
day
figur
calv
receiv
lr
restrain
later
recumb
skin
jugular
vein
scrub
chlorhexidinesalin
prepar
solut
spray
alcohol
placement
inch
cm
needl
skin
jugular
vein
clip
anim
facilit
blood
collect
fluid
administr
maintain
blind
studi
personnel
calf
fail
consum
given
nutrit
supplement
treatment
day
milk
replac
combin
refus
feed
administ
remain
volum
via
esophag
feeder
osmot
diarrhea
induc
period
accord
protocol
describ
walker
et
al
modif
hyperton
solut
milk
replac
sucros
fed
calv
enrol
induct
phase
commerci
milk
replac
nutra
blend
nutra
blend
llc
neosho
mo
use
throughout
studi
prepar
accord
direct
mix
sucros
solut
sucrosemilk
replac
mixtur
fed
volum
approxim
bw
per
feed
twice
day
deliv
approxim
gkg
sucros
per
feed
addit
halfstrength
milk
replac
frequenc
feed
hyperton
mixtur
done
need
induc
maintain
accept
fecal
score
fecal
charact
subject
assess
investig
either
jt
ts
feed
fecal
score
group
whole
deem
adequ
loos
wateri
littl
firm
materi
pen
standard
milk
replac
solut
fed
approxim
bw
per
feed
mani
stool
visibl
pen
normal
consist
sucros
solut
ad
milk
replac
administr
sucros
continu
need
throughout
treatment
period
fecal
consist
allow
return
normal
final
treatment
administ
hydrochlorothiazid
mgkg
oral
spironolacton
mgkg
oral
administ
everi
h
induct
calf
classifi
adequ
dehydr
enrol
treatment
calf
enrol
administr
diuret
ceas
hydrat
statu
calv
monitor
even
calv
enrol
either
h
initi
dehydr
protocol
base
upon
cumul
assess
bw
loss
target
approxim
moder
skin
tent
recess
eye
globe
within
orbit
mild
moder
depress
assess
done
singl
investig
mr
calv
adequ
dehydr
h
initi
trial
period
exclud
period
pretreat
treatment
posttreat
data
collect
done
calf
paramet
measur
assess
includ
bw
skin
tent
recess
eye
globe
within
socket
mentat
fecal
score
total
serum
protein
level
measur
via
optic
refractomet
follow
centrifug
pack
cell
volum
pcv
addit
sodium
potassium
bicarbon
level
base
excess
measur
via
handheld
instrument
istat
abbott
point
care
inc
princeton
nj
immedi
initi
induct
time
enrol
treatment
either
h
postinduct
even
treatment
one
day
complet
treatment
handheld
instrument
dispos
cartridg
commerci
avail
directli
measur
sodium
potassium
level
calcul
base
excess
bicarbon
valu
sampl
data
collect
throughout
trial
perform
individu
blind
treatment
mr
total
complet
observ
initi
posttreat
collect
use
statist
analysi
equal
number
desir
base
origin
power
calcul
mentat
score
eye
socket
recess
skin
tent
combin
form
composit
dehydr
score
efficaci
dehydr
protocol
assess
compar
analyt
within
calf
time
done
either
via
wilcoxon
rank
sum
nonnorm
distribut
measur
pair
ttest
normal
distribut
measur
kruskal
walli
oneway
anova
use
compar
composit
dehydr
score
base
excess
valu
initi
enrol
begin
treatment
complet
treatment
wherea
anova
repeat
measur
use
analyz
tp
pcv
electrolyt
within
calf
time
treatment
compar
wilcoxon
rank
sum
ttest
equal
varianc
assum
use
signific
differ
present
group
bw
p
dehydr
assess
score
p
serum
analyt
p
except
hco
p
initi
dehydr
protocol
administr
sucros
diuret
agent
result
profus
wateri
diarrhea
subsequ
moder
dehydr
per
protocol
achiev
almost
case
without
evid
profound
depress
recumb
loss
suckl
reflex
calv
experienc
averag
bw
loss
approxim
follow
induct
protocol
rang
gain
loss
mean
bw
induct
ie
initi
assess
kg
rang
versu
kg
rang
treatment
enrol
induct
initi
treatment
decreas
bw
statist
signific
p
serum
total
protein
pcv
valu
increas
enrol
compar
initi
assess
also
consist
dehydr
mean
total
protein
initi
assess
gdl
rang
compar
dehydr
time
enrol
treatment
rang
p
mean
pcv
rang
increas
rang
p
enrol
mean
calcul
base
excess
initi
assess
meql
rang
enrol
decreas
rang
p
calv
signific
differ
initi
enrol
lr
group
p
mean
bicarbon
concentr
initi
assess
meql
rang
treatment
enrol
decreas
rang
p
calv
signific
differ
initi
assess
time
enrol
lr
group
p
contrast
na
k
valu
significantli
differ
dehydr
treatment
compar
initi
evalu
vs
meql
p
vs
meql
p
signific
increas
observ
bw
time
treatment
enrol
complet
trial
complet
treatment
treatment
group
mean
weight
supplement
group
treatment
enrol
kg
rang
compar
mean
weight
trial
complet
rang
p
mean
weight
lr
group
enrol
kg
rang
complet
kg
rang
p
differ
observ
treatment
group
final
bw
chang
bw
induct
complet
p
similarli
total
protein
valu
pcv
base
excess
bicarbon
show
signific
chang
toward
baselin
treatment
enrol
complet
trial
test
period
see
tabl
signific
differ
observ
valu
treatment
group
signific
differ
observ
na
k
either
induct
final
treatment
protocol
major
find
summar
tabl
base
studi
report
iv
lr
commerci
avail
nutrit
supplement
effect
treatment
rehydr
mitig
acidbas
chang
moder
dehydr
diarrheic
calv
treatment
group
experienc
increas
bw
normal
base
excess
bicarbon
decreas
total
protein
pcv
upon
complet
treatment
improv
occur
face
continu
challeng
osmot
diarrhea
throughout
treatment
period
induct
diarrhea
discontinu
time
treatment
complet
simul
typic
manag
treat
calv
resolut
clinic
diseas
comparison
induct
initi
evalu
paramet
confirm
induct
protocol
success
replic
least
aspect
natur
diseas
includ
diarrhea
dehydr
shift
acidbas
statu
extrem
notabl
respons
protocol
observ
bw
calv
demonstr
averag
decreas
bw
time
initi
induct
protocol
enrol
treatment
howev
extrem
wide
rang
bw
chang
observ
increas
decreas
mani
factor
contribut
rel
rapid
chang
bw
includ
alter
gut
fill
prior
hydrat
statu
chang
gut
fill
almost
assuredli
influenc
extrem
observ
loss
bw
sole
primarili
attribut
fluid
loss
would
result
sever
dehydr
like
death
similarli
weight
gain
observ
small
number
calv
could
simpli
reflect
accumul
fluid
bowel
due
hyperosmolar
environ
onset
sever
diarrhea
small
part
byproduct
chosen
induct
protocol
would
expect
natur
diseas
recogn
limit
bw
paramet
measur
assess
hydrat
statu
subject
dehydr
score
increas
median
induct
dehydr
median
treatment
scale
includ
mentat
design
never
increas
paramet
includ
pcv
total
protein
bicarbon
base
excess
also
significantli
differ
baselin
induct
protocol
enrol
treatment
manner
consist
dehydr
moreov
paramet
significantli
differ
follow
treatment
compar
initi
treatment
confirm
success
treatment
approach
address
dehydr
metabol
derang
treatment
effect
return
bicarbon
base
excess
pcv
valu
significantli
differ
initi
baselin
bodi
weight
remain
significantli
lower
treatment
baselin
p
calv
examin
howev
lr
group
significantli
differ
baselin
complet
trial
p
bodi
weight
complet
trial
significantli
higher
induct
protocol
treatment
began
p
total
protein
also
lower
baselin
follow
treatment
p
may
reflect
loss
serum
protein
diarrheal
process
consumptiondecay
passiv
acquir
antibodi
may
simpli
reflect
dehydr
present
induct
process
correct
treatment
last
consider
overlook
previou
concurr
natur
challeng
variou
infecti
agent
could
contribut
degre
initi
dehydr
particularli
earli
studi
period
support
fact
calv
deem
ill
includ
initi
plan
period
retain
treat
includ
later
period
recov
affect
calv
remain
protocol
met
moder
dehydr
stand
suckl
criteria
uneven
distribut
ill
calv
exist
treatment
group
calf
mortal
occur
enrol
trial
period
one
due
clostridi
abomas
presum
induc
supraphysiolog
sucros
intak
second
result
sever
dehydr
failur
adequ
respond
treatment
although
intent
elicit
moder
dehydr
mortal
caus
induct
protocol
confirm
physiolog
burden
place
upon
calv
induct
process
addit
correct
dehydr
major
object
treatment
scour
calv
maintain
appropri
acidbas
statu
signific
chang
serum
bicarbon
valu
base
excess
show
treatment
success
revers
mild
metabol
imbal
metabol
acidosi
secondari
scour
result
combin
factor
includ
fecal
loss
bicarbon
decreas
tissu
perfus
hypoxia
lead
anaerob
glucos
metabol
subsequ
llactat
product
decreas
renal
effici
excret
excess
hydrogen
ion
well
dlactat
llactat
absorpt
increas
bacteri
ferment
nutrient
distal
gut
kasari
mainten
acidbas
balanc
critic
treat
calv
scour
due
associ
acidemia
depress
loss
suckl
well
hypothermia
shock
coma
sever
naylor
gener
calv
studi
develop
acidemia
indic
calcul
base
excess
bicarbon
valu
nonetheless
treatment
serv
assist
maintain
paramet
within
normal
rang
includ
facilit
statist
signific
chang
initi
conclus
treatment
unresolv
acidemia
scour
calv
associ
depress
loss
suckl
recumb
kasari
naylor
nakagawa
et
al
oral
administ
product
effect
practic
suckl
reflex
must
present
therefor
imper
metabol
acidosi
mild
quickli
control
ort
treatment
option
result
report
support
appropri
treatment
prevent
acidemia
calv
except
one
die
retain
strength
abil
stand
suckl
throughout
treatment
period
neither
induct
protocol
either
treatment
protocol
show
signific
effect
measur
electrolyt
level
consist
report
use
similar
model
leal
et
al
electrolyt
derang
scour
calv
variabl
difficult
predict
without
individu
analysi
michel
et
al
correct
hydrat
statu
electrolyt
loss
improv
ecf
volum
key
compon
rehydr
protocol
although
absenc
signific
chang
induct
protocol
make
imposs
assess
efficaci
either
treatment
correct
derang
nutrit
supplement
iv
lr
appear
adequ
assist
mainten
normal
electrolyt
paramet
throughout
follow
treatment
period
experiment
model
use
trial
identifi
treat
calv
moder
dehydr
calv
express
observ
clinic
sign
dehydr
bw
loss
suffer
derang
suffici
caus
sever
electrolyt
metabol
imbal
system
manifest
imbal
studi
may
warrant
assess
compar
efficaci
nutrit
supplement
examin
correct
electrolyt
imbal
sever
dehydr
calv
howev
ort
gener
consid
viabl
treatment
option
calv
still
abl
stand
demonstr
suckl
reflex
featur
often
absent
sever
diseas
smith
berchtold
induct
osmot
diarrhea
perfect
replic
natur
diseas
like
less
injuri
gastrointestin
mucosa
induc
diseas
mean
absorpt
oral
fluid
may
less
effici
natur
diseas
howev
use
calv
affect
natur
diseas
studi
fraught
difficulti
specif
etiolog
typic
unknown
natur
diseas
challeng
burden
insult
gut
risk
calf
unknow
inconsist
use
calv
suffer
natur
diseas
would
also
preclud
crossov
studi
design
given
consider
decid
use
wellestablish
proven
experiment
induct
model
studi
warrant
assess
efficaci
nutrit
supplement
natur
diseas
washout
period
chosen
permit
calv
digest
tract
return
normal
calv
achiev
normal
hydrat
statu
challeng
episod
length
interv
arbitrari
seem
adequ
stool
typic
normal
h
final
sucros
feed
subject
score
time
enrol
suggest
calv
adequ
rehydr
enter
next
trial
period
volum
fluid
provid
treatment
notabl
differ
l
daili
nutrit
supplement
l
iv
treatment
may
lead
question
regard
appropri
compar
approach
studi
design
attempt
account
sever
consider
make
differ
volum
appropri
first
import
follow
manufactur
recommend
nutrit
supplement
second
sought
consist
practic
field
either
therapi
intraven
fluid
therapi
primarili
use
field
calv
sever
affect
studi
howev
larg
calf
ranch
often
prefer
use
iv
fluid
firstlin
treatment
assumpt
effect
oral
administ
product
even
situat
iv
treatment
typic
feasibl
day
studi
protocol
reflect
limit
similarli
administr
l
short
period
time
would
pose
risk
fluid
overload
particularli
hypoproteinem
calv
volum
overload
via
oral
administr
much
less
like
occur
almost
inconceiv
balanc
electrolyt
product
use
report
moreov
absorpt
fluid
gut
less
particularli
face
diarrheal
diseas
thu
larger
volum
justifi
oral
treatment
compar
iv
lactat
ringer
solut
use
iv
fluid
choic
commerci
avail
commonli
use
replac
fluid
polyion
fluid
close
mirror
physiolog
fluid
sodium
chlorid
inclus
lactat
provid
substrat
serv
alkal
agent
follow
metabol
liver
benefici
reduc
acidosi
typic
scour
calv
wherea
sodium
chlorid
provid
strong
cationanion
ratio
exert
acidifi
effect
although
commerci
avail
product
provid
slightli
higher
sodium
content
along
metaboliz
base
differ
gener
deem
clinic
insignific
distinct
product
lr
normosol
r
pfizer
new
york
ny
plasmalyt
baxter
deerfield
il
although
limit
evid
compar
efficaci
balanc
solut
current
littl
clinic
differ
seen
noritomi
et
al
sever
acidot
calv
benefit
isoton
hyperton
sodium
bicarbon
acet
lactat
ringer
solut
prefer
mildli
affect
calv
berchtold
crossov
studi
design
allow
calv
use
multipl
studi
period
throughout
trial
meant
wide
age
gap
present
first
last
period
diarrheaassoci
dehydr
concern
prewean
calv
studi
design
encompass
suscept
age
calv
howev
small
number
calv
period
preclud
analysi
age
group
research
warrant
studi
variat
efficaci
treatment
differ
calf
age
group
labor
facil
limit
necessit
less
optim
schedul
feed
supplement
deliveri
calv
receiv
milk
replac
h
h
administr
supplement
approxim
h
despit
rel
larg
volum
fluid
quart
l
milk
replac
quart
l
supplement
offer
interv
refus
loss
appetit
never
necessit
administr
milk
supplement
via
esophag
feeder
calv
consum
littl
daili
milk
feed
esophag
feed
occur
calv
equal
distribut
treatment
group
would
seem
demonstr
dehydr
calv
voluntarili
consum
rel
larg
volum
fluid
concern
refus
need
administ
via
esophag
feeder
unjustifi
calf
readili
consum
milk
supplement
calf
assess
see
either
dehydr
lost
suckl
reflex
due
sever
dehydr
acidemia
prevent
manag
treatment
diarrhea
prewean
calv
great
import
anim
health
econom
oper
best
manag
incorpor
multimod
prevent
approach
focus
decreas
diseas
burden
support
calf
immun
well
implement
treatment
protocol
allow
earli
detect
earli
action
protocol
design
allow
rapid
consist
rehydr
userfriendli
effici
studi
indic
calv
moder
dehydr
induc
hyperosmot
diarrhea
effect
rehydr
iv
lr
well
commerci
nutrit
supplement
proven
effect
oral
rehydr
supplement
effect
treatment
option
give
produc
safe
easi
use
altern
administ
iv
fluid
protocol
enabl
better
treat
diarrhea
prevent
calfhood
mortal
